These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26895143)

  • 1. Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.
    Dampier C; Barry V; Gross HE; Lui Y; Thornburg CD; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1031-7. PubMed ID: 26895143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.
    Dampier C; Jaeger B; Gross HE; Barry V; Edwards L; Lui Y; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1038-45. PubMed ID: 26853841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.
    DeWalt DA; Gross HE; Gipson DS; Selewski DT; DeWitt EM; Dampier CD; Hinds PS; Huang IC; Thissen D; Varni JW
    Qual Life Res; 2015 Sep; 24(9):2195-208. PubMed ID: 25715946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing responsiveness over time of the PROMIS
    Reeve BB; Edwards LJ; Jaeger BC; Hinds PS; Dampier C; Gipson DS; Selewski DT; Troost JP; Thissen D; Barry V; Gross HE; DeWalt DA
    Qual Life Res; 2018 Jan; 27(1):249-257. PubMed ID: 28884421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease.
    Singh A; DasGupta M; Simpson PM; Panepinto JA
    Pediatr Blood Cancer; 2019 May; 66(5):e27633. PubMed ID: 30688017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.
    Keller S; Yang M; Treadwell MJ; Hassell KL
    Health Qual Life Outcomes; 2017 Jun; 15(1):117. PubMed ID: 28577358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.
    Selewski DT; Troost JP; Cummings D; Massengill SF; Gbadegesin RA; Greenbaum LA; Shatat IF; Cai Y; Kapur G; Hebert D; Somers MJ; Trachtman H; Pais P; Seifert ME; Goebel J; Sethna CB; Mahan JD; Gross HE; Herreshoff E; Liu Y; Carlozzi NE; Reeve BB; DeWalt DA; Gipson DS
    Health Qual Life Outcomes; 2017 Aug; 15(1):166. PubMed ID: 28835233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising insights into the health related quality of life for children with severe obesity.
    Selewski DT; Collier DN; MacHardy J; Gross HE; Pickens EM; Cooper AW; Bullock S; Earls MF; Pratt KJ; Scanlon K; McNeill JD; Messer KL; Lu Y; Thissen D; DeWalt DA; Gipson DS
    Health Qual Life Outcomes; 2013 Mar; 11():29. PubMed ID: 23452863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can PROMIS domains of pain and physical functioning detect changes in health over time for children with sickle cell disease?
    Singh A; Dasgupta M; Simpson PM; Brousseau DC; Panepinto JA
    Pediatr Blood Cancer; 2020 May; 67(5):e28203. PubMed ID: 32026613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study.
    Selewski DT; Massengill SF; Troost JP; Wickman L; Messer KL; Herreshoff E; Bowers C; Ferris ME; Mahan JD; Greenbaum LA; MacHardy J; Kapur G; Chand DH; Goebel J; Barletta GM; Geary D; Kershaw DB; Pan CG; Gbadegesin R; Hidalgo G; Lane JC; Leiser JD; Song PX; Thissen D; Liu Y; Gross HE; DeWalt DA; Gipson DS
    Pediatr Nephrol; 2014 Dec; 29(12):2347-56. PubMed ID: 24908324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease.
    Hildenbrand AK; Quinn CT; Mara CA; Peugh JL; McTate EA; Britto MT; Crosby LE
    Health Psychol; 2019 May; 38(5):386-390. PubMed ID: 31045421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease.
    Badawy SM; Barrera L; Cai S; Thompson AA
    Biomed Res Int; 2018; 2018():8296139. PubMed ID: 30105252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical meaning of PROMIS pain domains for children with sickle cell disease.
    Singh A; Panepinto JA
    Blood Adv; 2019 Aug; 3(15):2244-2249. PubMed ID: 31345791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotion regulation, pain interference and affective symptoms in children and adolescents with sickle cell disease.
    Miller M; Balsamo L; Pashankar F; Bailey CS
    J Affect Disord; 2021 Mar; 282():829-835. PubMed ID: 33601724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using item response theory to enrich and expand the PROMIS® pediatric self report banks.
    Quinn H; Thissen D; Liu Y; Magnus B; Lai JS; Amtmann D; Varni JW; Gross HE; DeWalt DA
    Health Qual Life Outcomes; 2014 Oct; 12():160. PubMed ID: 25344155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.
    Reeve BB; McFatrich M; Mack JW; Pinheiro LC; Jacobs SS; Baker JN; Withycombe JS; Lin L; Mann CM; Villabroza KR; Hinds PS
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28160. PubMed ID: 31904157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study.
    Gipson DS; Selewski DT; Massengill SF; Wickman L; Messer KL; Herreshoff E; Bowers C; Ferris ME; Mahan JD; Greenbaum LA; MacHardy J; Kapur G; Chand DH; Goebel J; Barletta GM; Geary D; Kershaw DB; Pan CG; Gbadegesin R; Hidalgo G; Lane JC; Leiser JD; Plattner BW; Song PX; Thissen D; Liu Y; Gross HE; DeWalt DA
    Health Qual Life Outcomes; 2013 Mar; 11():30. PubMed ID: 23510630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation, psychometric validation, and baseline results of the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric measures to assess health-related quality of life of patients with pediatric lymphoma in Malawi.
    Westmoreland K; Reeve BB; Amuquandoh A; van der Gronde T; Manthalu O; Correia H; Stanley C; Itimu S; Salima A; Chikasema M; Ward P; Mpasa A; Wachepa S; Mtete I; Butia M; Chasela M; Mtunda M; Wasswa P; Martin S; Kim NE; Kazembe P; Gopal S
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27353. PubMed ID: 30015407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.